Robert J. Lefkowitz - Apr 30, 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Robert J. Lefkowitz
Stock symbol
LXRX
Transactions as of
Apr 30, 2022
Transactions value $
$0
Form type
4
Date filed
5/2/2022, 04:15 PM
Next filing
May 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +4.02K +14.9% $0.00 31K Apr 30, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -4.02K -100% $0.00* 0 Apr 30, 2022 Common Stock 4.02K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.